Literature DB >> 17280833

Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and preliminary SAR.

Erin F DiMauro1, John Newcomb, Joseph J Nunes, Jean E Bemis, Christina Boucher, John L Buchanan, William H Buckner, Alan Cheng, Theodore Faust, Faye Hsieh, Xin Huang, Josie H Lee, Teresa L Marshall, Matthew W Martin, David C McGowan, Stephen Schneider, Susan M Turci, Ryan D White, Xiaotian Zhu.   

Abstract

4-Amino-5,6-biaryl-furo[2,3-d]pyrimidines were identified as potent non-selective inhibitors of Lck. A novel, divergent, and practical synthetic route was developed to access derivatives from bifunctional intermediates. Lead optimization was guided by X-ray crystallographic data, and preliminary SAR led to the identification of compounds with improved cellular potency and selectivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280833     DOI: 10.1016/j.bmcl.2007.01.057

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity.

Authors:  Kiran Mahajan; Sridevi Challa; Domenico Coppola; Harshani Lawrence; Yunting Luo; Harsukh Gevariya; Weiwei Zhu; Y Ann Chen; Nicholas J Lawrence; Nupam P Mahajan
Journal:  Prostate       Date:  2010-09-01       Impact factor: 4.104

Review 2.  Shepherding AKT and androgen receptor by Ack1 tyrosine kinase.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2010-08       Impact factor: 6.384

3.  High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.

Authors:  Chandrasekhar V Miduturu; Xianming Deng; Nicholas Kwiatkowski; Wannian Yang; Laurent Brault; Panagis Filippakopoulos; Eunah Chung; Qingkai Yang; Juerg Schwaller; Stefan Knapp; Randall W King; Jiing-Dwan Lee; Sanna Herrgard; Patrick Zarrinkar; Nathanael S Gray
Journal:  Chem Biol       Date:  2011-07-29

4.  Development of novel ACK1/TNK2 inhibitors using a fragment-based approach.

Authors:  Harshani R Lawrence; Kiran Mahajan; Yunting Luo; Daniel Zhang; Nathan Tindall; Miles Huseyin; Harsukh Gevariya; Sakib Kazi; Sevil Ozcan; Nupam P Mahajan; Nicholas J Lawrence
Journal:  J Med Chem       Date:  2015-03-17       Impact factor: 7.446

5.  Ack1 tyrosine kinase activation correlates with pancreatic cancer progression.

Authors:  Kiran Mahajan; Domenico Coppola; Y Ann Chen; Weiwei Zhu; Harshani R Lawrence; Nicholas J Lawrence; Nupam P Mahajan
Journal:  Am J Pathol       Date:  2012-02-07       Impact factor: 4.307

Review 6.  ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferation.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  Cancer Lett       Date:  2013-04-15       Impact factor: 8.679

7.  Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds.

Authors:  Lori Emert-Sedlak; Toshiaki Kodama; Edwina C Lerner; Weixiang Dai; Caleb Foster; Billy W Day; John S Lazo; Thomas E Smithgall
Journal:  ACS Chem Biol       Date:  2009-11-20       Impact factor: 5.100

8.  Ack1-mediated androgen receptor phosphorylation modulates radiation resistance in castration-resistant prostate cancer.

Authors:  Kiran Mahajan; Domenico Coppola; Bhupendra Rawal; Y Ann Chen; Harshani R Lawrence; Robert W Engelman; Nicholas J Lawrence; Nupam P Mahajan
Journal:  J Biol Chem       Date:  2012-05-07       Impact factor: 5.157

9.  Merging catalyst-free synthesis and iodine catalysis: one-pot synthesis of dihydrofuropyrimidines and spirodihydrofuropyrimidine pyrazolones.

Authors:  Ya-Yun Zheng; Kai-Xiang Feng; Ai-Bao Xia; Jie Liu; Cheng-Ke Tang; Zhan-Yu Zhou; Dan-Qian Xu
Journal:  RSC Adv       Date:  2019-03-27       Impact factor: 3.361

10.  New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011-2021) focussing on structure-activity relationship (SAR) and docking insights.

Authors:  Ahmed Elkamhawy; Eslam M H Ali; Kyeong Lee
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.